X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (3869) 3869
animals (3800) 3800
humans (3098) 3098
rats (2138) 2138
female (2118) 2118
muscarinic antagonists - pharmacology (1695) 1695
pharmacology & pharmacy (1645) 1645
neurosciences (1596) 1596
muscarinic antagonists - administration & dosage (1441) 1441
muscarinic antagonists - therapeutic use (1136) 1136
middle aged (1077) 1077
dose-response relationship, drug (1037) 1037
adult (968) 968
mice (882) 882
aged (866) 866
acetylcholine (844) 844
rats, sprague-dawley (811) 811
muscarinic receptors (762) 762
treatment outcome (746) 746
atropine - pharmacology (740) 740
rats, wistar (690) 690
receptors, muscarinic - drug effects (650) 650
muscarinic antagonists - adverse effects (634) 634
receptors, muscarinic - metabolism (612) 612
pulmonary disease, chronic obstructive - drug therapy (579) 579
time factors (579) 579
scopolamine (558) 558
acetylcholine receptors (520) 520
overactive bladder (496) 496
administration, inhalation (484) 484
respiratory system (482) 482
physiology (480) 480
urinary bladder, overactive - drug therapy (474) 474
analysis (465) 465
muscarinic agonists - pharmacology (464) 464
urology & nephrology (462) 462
double-blind method (454) 454
brain (450) 450
receptors, muscarinic - physiology (448) 448
receptors (447) 447
efficacy (446) 446
atropine (436) 436
rat (435) 435
drug therapy (423) 423
drug therapy, combination (399) 399
memory (396) 396
research (395) 395
psychiatry (394) 394
muscarinic antagonists (384) 384
in vitro techniques (382) 382
neurons (377) 377
rodents (376) 376
disease models, animal (370) 370
double-blind (369) 369
care and treatment (364) 364
urinary incontinence (355) 355
copd (354) 354
muscarinic receptor (348) 348
chronic obstructive pulmonary disease (341) 341
bronchodilator agents - administration & dosage (335) 335
alzheimers-disease (334) 334
obstructive pulmonary-disease (320) 320
safety (318) 318
lung diseases, obstructive (316) 316
scopolamine hydrobromide - pharmacology (313) 313
carbachol - pharmacology (312) 312
medicine & public health (311) 311
heart rate - drug effects (308) 308
tiotropium (306) 306
aged, 80 and over (303) 303
acetylcholine - metabolism (300) 300
dosage and administration (298) 298
pulmonary disease, chronic obstructive - physiopathology (291) 291
pharmacology (288) 288
biomedicine (279) 279
neurology (274) 274
pharmacology/toxicology (273) 273
atropine - administration & dosage (272) 272
hippocampus (272) 272
quality of life (271) 271
tolterodine (270) 270
adolescent (269) 269
physiological aspects (267) 267
asthma (262) 262
biochemistry & molecular biology (261) 261
tolterodine tartrate (260) 260
clinical neurology (255) 255
oxybutynin (255) 255
behavioral sciences (250) 250
drugs (249) 249
blood pressure - drug effects (247) 247
drug interactions (245) 245
muscarinic (243) 243
toxicology (242) 242
muscle contraction - drug effects (239) 239
electric stimulation (237) 237
dopamine (236) 236
acetylcholine - pharmacology (233) 233
muscarinic antagonists - pharmacokinetics (232) 232
hippocampus - drug effects (231) 231
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6850) 6850
Japanese (76) 76
Russian (52) 52
German (40) 40
Spanish (17) 17
Chinese (13) 13
French (13) 13
Portuguese (6) 6
Danish (5) 5
Polish (5) 5
Ukrainian (5) 5
Dutch (4) 4
Italian (4) 4
Czech (3) 3
Korean (2) 2
Norwegian (2) 2
Swedish (2) 2
Bulgarian (1) 1
Hebrew (1) 1
Hungarian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1465-1858, 08/2018, Volume 2018, Issue 8, p. CD012355
Journal Article
Journal Article
Psychopharmacology (Berlin, Germany), ISSN 1432-2072, 2012, Volume 224, Issue 4, pp. 489 - 499
...ORIGINAL INVESTIGA TION Effects of acute administration of nicotinic and muscarinic cholinergic agonists and antagonists on performance in different cost... 
Nicotinic | Neurosciences | Impulsivity | Perseveration | Biomedicine | Muscarinic | Risk | Delay discounting | Pharmacology/Toxicology | Psychiatry | Cholinergic | Probability discounting | YOUNG-ADULTS | ACETYLCHOLINE | PSYCHIATRY | FOOD-INTAKE | BEHAVIOR | SMOKING | REWARD | NEUROSCIENCES | SMOKERS | IMPULSIVE CHOICE | LOW-DOSE MECAMYLAMINE | PHARMACOLOGY & PHARMACY | AMPHETAMINE | Choice Behavior - drug effects | Nicotine - administration & dosage | Rats, Long-Evans | Decision Making - drug effects | Probability | Rats | Atropine - pharmacology | Male | Nicotine - pharmacology | Dose-Response Relationship, Drug | Muscarinic Antagonists - administration & dosage | Nicotinic Agonists - administration & dosage | Scopolamine Hydrobromide - pharmacology | Animals | Muscarinic Antagonists - pharmacology | Cost-Benefit Analysis | Scopolamine Hydrobromide - administration & dosage | Atropine - administration & dosage | Reward | Nicotinic Agonists - pharmacology | Decision-making | Economic aspects | Schizophrenia | Cost benefit analysis | Attention-deficit hyperactivity disorder | Drug addiction | Behavioral decision theory | Psychopharmacology | Benefit cost analysis | Scopolamine | Acetylcholine receptors (muscarinic) | Mental disorders | Decision making | Therapeutic applications | Attention deficit hyperactivity disorder | Data processing | Antagonists | mecamylamine | oxotremorine | Addiction | Etiology | Acetylcholine receptors | Atropine | Reinforcement | Acetylcholine receptors (nicotinic) | Cholinergic transmission | Nicotine
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 6, pp. 1003 - 1012
Journal Article
Journal Article
Journal Article